Silvia Sookoian

1999–2026 年に発表

94
論文数
21,630
被引用数
65
h 指数
90
i10 指数

被引用数

Silvia Sookoian の年別被引用数1995 年: 被引用 1 件1997 年: 被引用 1 件2001 年: 被引用 11 件2002 年: 被引用 5 件2003 年: 被引用 7 件2004 年: 被引用 3 件2005 年: 被引用 3 件2006 年: 被引用 4 件2007 年: 被引用 9 件2008 年: 被引用 32 件2009 年: 被引用 40 件2010 年: 被引用 74 件2011 年: 被引用 68 件2012 年: 被引用 78 件2013 年: 被引用 112 件2014 年: 被引用 115 件2015 年: 被引用 150 件2016 年: 被引用 179 件2017 年: 被引用 152 件2018 年: 被引用 146 件2019 年: 被引用 429 件2020 年: 被引用 825 件2021 年: 被引用 921 件2022 年: 被引用 825 件2023 年: 被引用 740 件2024 年: 被引用 1,865 件2025 年: 被引用 1,143 件2026 年: 被引用 37 件1996 年は被引用が無いため表示していません1998〜2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,850 件、この内訳の 16.5%中国: 引用元論文 1,707 件、この内訳の 15.2%イタリア: 引用元論文 761 件、この内訳の 6.8%イギリス: 引用元論文 603 件、この内訳の 5.4%ドイツ: 引用元論文 410 件、この内訳の 3.7%スペイン: 引用元論文 389 件、この内訳の 3.5%韓国: 引用元論文 350 件、この内訳の 3.1%日本: 引用元論文 324 件、この内訳の 2.9%オーストラリア: 引用元論文 293 件、この内訳の 2.6%フランス: 引用元論文 271 件、この内訳の 2.4%カナダ: 引用元論文 210 件、この内訳の 1.9%スウェーデン: 引用元論文 201 件、この内訳の 1.8%
0%16.5%その他 34.2%

分野

  • Medicine79.8%
  • Biochemistry, Genetics and Molecular Biology12%
  • Neuroscience2.9%
  • Psychology1.1%
  • Immunology and Microbiology0.9%
  • Environmental Science0.7%
  • その他2.6%

トピック

  • Liver Disease Diagnosis and Treatment24.1%
  • Diet, Metabolism, and Disease6.6%
  • Liver Disease and Transplantation5.4%
  • Diabetes, Cardiovascular Risks, and Lipoproteins3.8%
  • Alcohol Consumption and Health Effects3.8%
  • Diet and metabolism studies2.6%
  • その他53.7%

共著者

全論文

検索で開く
  1. A multisociety Delphi consensus statement on new fatty liver disease nomenclature

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marko Korenjak, Kris V. Kowdley, Florence Lacaille, Rohit Loomba, Robert Mitchell-Thain, Timothy R. Morgan, Elisabeth E. Powell, Michael Roden, Manuel Romero‐Gómez, Marcelo Silva, Shivaram Prasad Singh, Silvia Sookoian, C Wendy Spearman, Dina Tiniakos, Luca Valenti, Miriam B. Vos, Vincent Wai‐Sun Wong, Stavra A. Xanthakos, Yusuf Yılmaz, Zobair M. Younossi, Ansley Hobbs, Marcela Villota‐Rivas, Philip N. Newsome, on behalf of the NAFLD Nomenclature consensus group - Hepatology 2023 被引用: 2,904

  2. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vincent Wai‐Sun Wong, Vlad Ratziu, Yusuf Yılmaz, Zobair M. Younossi - Gastroenterology 2020 被引用: 3,274

  3. A multisociety Delphi consensus statement on new fatty liver disease nomenclature

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marko Korenjak, Kris V. Kowdley, Florence Lacaille, Rohit Loomba, Robert Mitchell-Thain, Timothy R. Morgan, Elisabeth E. Powell, Michael Roden, Manuel Romero‐Gómez, Marcelo Silva, Shivaram Prasad Singh, Silvia Sookoian, C Wendy Spearman, Dina Tiniakos, Luca Valenti, Miriam B. Vos, Vincent Wai‐Sun Wong, Stavra A. Xanthakos, Yusuf Yılmaz, Zobair M. Younossi, Ansley Hobbs, Marcela Villota‐Rivas, Philip N. Newsome - Annals of Hepatology 2023 被引用: 2,698

  4. Alcohol consumption and metabolic syndrome: Clinical and epidemiological impact on liver disease

    著者: , , , , - Journal of Hepatology 2022 被引用: 279

  5. Nonalcoholic fatty liver disease

    著者: , , , , , , , , , - Nature Reviews Disease Primers 2015 被引用: 841

  6. Global burden of metabolic diseases, 1990–2021

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Leon A. Adams, Said A. Al‐Busafi, Ala I. Sharara, Wah‐Kheong Chan, Syed Imran Abbas, Silvia Sookoian, Sombat Treeprasertsuk, Ponsiano Ocama, Khalid Alswat, Alice P.S. Kong, Karim Ataya, Michelle Ching Lim-Loo, Rodolfo J. Oviedo, Olivia Szepietowski, Yasser Fouad, Huijie Zhang, Tamer N Abdelbaki, Christos S. Katsouras, Arun Prasad, Omar Thaher, Arshad Ali, Gabriel A Molina, Ki‐Chul Sung, Qin‐Fen Chen, Cosmas Rinaldi Adithya Lesmana, Ming‐Hua Zheng - Metabolism 2024 被引用: 302

  7. Noninvasive biomarkers in NAFLD and NASH — current progress and future promise

    著者: , , , , - Nature Reviews Gastroenterology & Hepatology 2018 被引用: 620

  8. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease

    著者: , - Hepatology 2011 被引用: 910

  9. From NAFLD to MASLD: updated naming and diagnosis criteria for fatty liver disease

    著者: , - Journal of Lipid Research 2023 被引用: 207

  10. Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yasser Fouad, Christos S. Mantzoros, Huijie Zhang, Nahúm Méndez‐Sánchez, Silvia Sookoian, Wah‐Kheong Chan, Sombat Treeprasertsuk, Leon A. Adams, Ponsiano Ocama, John Ryan, Nilanka Perera, Ala I. Sharara, Said A. Al‐Busafi, Christopher Opio, Manuel Garcia, Michelle Ching Lim-Loo, Elena Ruiz‐Úcar, Arun Prasad, Anna Casajoana, Tamer N. Abdelbaki, Ming‐Hua Zheng - EClinicalMedicine 2024 被引用: 191

  11. Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease

    著者: , , , , , , - Gut 2020 被引用: 221

  12. Geographical similarity and differences in the burden and genetic predisposition of NAFLD

    著者: , , , , , , , , - Hepatology 2022 被引用: 120

  13. An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ajay Duseja, Adriaan G. Holleboom, Junping Shi, Wah‐Kheong Chan, Yasser Fouad, Junwei Yang, Sombat Treeprasertsuk, Helena Cortez‐Pinto, Masahide Hamaguchi, Manuel Romero‐Gómez, Mamun Al Mahtab, Ponsiano Ocama, Atsushi Nakajima, Chunsun Dai, Mohammed Eslam, Lai Wei, Jacob George, Ming‐Hua Zheng - HepatoBiliary Surgery and Nutrition 2023 被引用: 88

  14. Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis

    著者: , , , , , , , , , - Gut 2014 被引用: 549

  15. Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems Biology

    著者: , , , - Hepatology 2020 被引用: 128

  16. The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giada Sebastiani, Vincent Wai‐Sun Wong, Fredrik Åberg, Yu Jun Wong, Pian-hong Zhang, Francisco J. Bermúdez‐Silva, Yan Ni, Monica Lupșor‐Platon, Wah‐Kheong Chan, Nahúm Méndez‐Sánchez, Robert J. de Knegt, Shahinul Alam, Sombat Treeprasertsuk, Li Wang, Mulong Du, Tiejun Zhang, Ming‐Lung Yu, Huijie Zhang, Xingshun Qi, Xin Liu, Kanokwan Pinyopornpanish, Yu‐Chen Fan, Kaijun Niu, Josep C. Jiménez‐Chillarón, Ming‐Hua Zheng - Metabolism 2024 被引用: 111

  17. Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease

    著者: , , , , , , , , - Gut 2012 被引用: 359

  18. Liver enzymes, metabolomics and genome-wide association studies: From systems biology to the personalized medicine

    著者: , - World Journal of Gastroenterology 2015 被引用: 342

  19. Genetics of Metabolic Dysfunction-associated Steatotic Liver Disease: The State of the Art Update

    著者: , , - Clinical Gastroenterology and Hepatology 2024 被引用: 65

  20. Epigenetic Regulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease

    著者: , , , , , , - Hepatology 2010 被引用: 326

  21. Impact of the Association Between PNPLA3 Genetic Variation and Dietary Intake on the Risk of Significant Fibrosis in Patients With NAFLD

    著者: , , , , , , , - The American Journal of Gastroenterology 2020 被引用: 66

  22. Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Saeed Hamid, Nilanka Perera, Khalid Alswat, Qiuwei Pan, Michelle T. Long, Isakov Va, Man Mi, Marco Arrese, Arun J. Sanyal, Shiv Kumar Sarin, Nathalie C. Leite, Luca Valenti, Philip N. Newsome, Hannes Hagström, Salvatore Petta, Hannele Yki‐Järvinen, Jörn M. Schattenberg, Marlén Castellanos, Isabelle Leclercq, Gulnara Aghayeva, Abdel‐Naser Elzouki, Ali Tumi, Ala I. Sharara, Asma Labidi, Faisal M. Sanai, Khaled Matar‎, Maen Almattooq, Maisam Akroush, Mustapha Benazzouz, Nabil Debzi, Maryam Alkhatry, Salma Barakat, Said A. Al‐Busafi, John Rwegasha, Wah Yang, Adwoa Agyei‐Nkansah, Christopher Opio, Mohammadjavad Sotoudeheian, Yu Jun Wong, Jacob George, Ming‐Hua Zheng - JHEP Reports 2024 被引用: 94

  23. Systematic review with meta‐analysis: risk factors for non‐alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients

    著者: , - Alimentary Pharmacology & Therapeutics 2017 被引用: 230

  24. Liver mitochondrial DNA damage and genetic variability of Cytochrome b – a key component of the respirasome – drive the severity of fatty liver disease

    著者: , , , , - Journal of Internal Medicine 2020 被引用: 60